Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment
The main purpose of this study is to evaluate the efficacy and safety of 3 doses of Somatuline Autogel 60mg to control the muscle infiltration and edema, eyelid retraction and extraocular muscular contraction in patients with active thyroid-associated ophthalmopathy of moderate intensity.
Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment
- 04 December 2024 - 1 mins read
The main purpose of this study is to evaluate the efficacy and safety of 3 doses of Somatuline Autogel 60mg to control the muscle infiltration and edema, eyelid retraction and extraocular muscular contraction in patients with active thyroid-associated ophthalmopathy of moderate intensity.
Related Clinical Trials
04 December 2024
1 mins read
A Long-Term Study of Elafibranor in Adult Participants with Primary Biliary Cholangitis
04 December 2024
1 mins read
A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants with Primary Sclerosing Cholangitis.
04 December 2024
1 mins read
A Study to Evaluate the Effect of Food on the Level of Circulating Elafibranor in Healthy Participants after Intake of a Single Tablet
04 December 2024
1 mins read
Study to Compare the Level of Elafibranor in Blood after Repeat Administration in Japanese and non-Asian Healthy Participants
04 December 2024
1 mins read
A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ?14 Years With Fibrodysplasia Ossificans Progressiva...
04 December 2024
1 mins read
Effects of maintenance cabozantinib+BSC versus BSC in children and AYA with osteosarcoma.
04 December 2024
2 mins read
A study to evaluate the effectiveness and safety of Dysport® for the prevention of episodic migraine in adults
04 December 2024
2 mins read
A study to evaluate the effectiveness and safety of Dysport® for the prevention of chronic migraine in adults
04 December 2024
1 mins read
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
04 December 2024
2 mins read